Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Joshua Kennedy

Concepts (248)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
20
2024
282
5.610
Why?
Picornaviridae Infections
10
2022
18
3.670
Why?
Rhinovirus
13
2022
22
3.380
Why?
Virus Diseases
4
2024
40
2.650
Why?
Rhinitis
5
2018
26
2.450
Why?
Sinusitis
5
2018
42
2.390
Why?
Desensitization, Immunologic
5
2018
106
2.000
Why?
Hypersensitivity
6
2022
75
1.650
Why?
Lung
4
2024
512
1.260
Why?
Drug Hypersensitivity
3
2018
37
1.220
Why?
Respiratory Hypersensitivity
4
2020
17
1.080
Why?
Respiratory Tract Infections
3
2024
76
1.040
Why?
Disaccharides
2
2015
10
0.940
Why?
Immunoglobulin E
8
2020
92
0.930
Why?
Urticaria
2
2015
18
0.930
Why?
Rhinitis, Allergic, Perennial
2
2014
4
0.920
Why?
Androstadienes
2
2014
10
0.920
Why?
Meat
2
2015
61
0.920
Why?
Rhinitis, Allergic, Seasonal
2
2014
8
0.910
Why?
Coinfection
1
2024
41
0.880
Why?
Respiratory Sounds
5
2022
48
0.880
Why?
Viruses
1
2023
21
0.860
Why?
Humans
48
2024
50389
0.840
Why?
Pharyngitis
1
2022
16
0.830
Why?
Carbachol
3
2020
27
0.800
Why?
Streptococcal Infections
1
2022
46
0.800
Why?
Hospitalization
2
2024
668
0.760
Why?
Allergens
6
2019
136
0.680
Why?
Rural Population
1
2024
552
0.680
Why?
Child
14
2024
6877
0.670
Why?
Eosinophils
3
2017
41
0.670
Why?
Th2 Cells
2
2016
22
0.650
Why?
Bronchoconstriction
1
2019
6
0.640
Why?
Anaphylaxis
2
2018
70
0.630
Why?
Aspirin
2
2017
111
0.630
Why?
Bronchodilator Agents
2
2019
75
0.610
Why?
Mesalamine
1
2017
12
0.560
Why?
Ketorolac
1
2016
3
0.550
Why?
Itraconazole
1
2016
41
0.540
Why?
Colitis, Ulcerative
1
2017
53
0.540
Why?
Staphylococcus
2
2013
35
0.530
Why?
Viral Load
3
2022
76
0.530
Why?
Food Hypersensitivity
2
2019
97
0.530
Why?
Acetaminophen
1
2019
274
0.520
Why?
Immunologic Factors
1
2016
111
0.510
Why?
Arkansas
7
2024
1991
0.490
Why?
Child, Preschool
8
2024
3908
0.470
Why?
Adolescent
13
2024
6475
0.450
Why?
Candidiasis
1
2014
114
0.440
Why?
Allergy and Immunology
1
2013
19
0.440
Why?
Hypersensitivity, Delayed
1
2013
19
0.430
Why?
Lymphangitis
1
2013
2
0.430
Why?
Manikins
1
2013
35
0.430
Why?
Male
19
2024
25718
0.430
Why?
Emergency Medicine
1
2013
52
0.430
Why?
Bronchi
1
2012
44
0.410
Why?
Pruritus
1
2013
44
0.410
Why?
Eosinophilia
1
2013
36
0.400
Why?
Common Cold
1
2012
5
0.400
Why?
Edema
1
2013
68
0.400
Why?
Animals
12
2024
13173
0.390
Why?
Chronic Disease
4
2016
570
0.380
Why?
Enterovirus Infections
2
2022
5
0.380
Why?
Female
18
2024
26981
0.370
Why?
Eosinophilic Esophagitis
2
2024
38
0.370
Why?
Esophagus
2
2024
83
0.360
Why?
Pediatrics
1
2013
280
0.350
Why?
Staphylococcal Infections
1
2013
269
0.340
Why?
Emergency Service, Hospital
2
2024
482
0.330
Why?
Cytokines
3
2024
606
0.320
Why?
Interferons
2
2022
38
0.320
Why?
Diagnosis, Differential
3
2018
1042
0.310
Why?
Anti-Allergic Agents
2
2020
16
0.310
Why?
Pandemics
2
2024
564
0.300
Why?
Anti-Bacterial Agents
1
2013
745
0.290
Why?
Bacteria
2
2023
220
0.290
Why?
Age Factors
3
2024
1104
0.290
Why?
Immunity, Innate
3
2024
105
0.290
Why?
Young Adult
6
2023
4064
0.280
Why?
Adult
11
2023
13568
0.270
Why?
Disease Progression
3
2020
823
0.260
Why?
Interleukins
2
2015
32
0.230
Why?
Mycoplasma pneumoniae
1
2024
4
0.230
Why?
Regeneration
1
2024
74
0.230
Why?
Skin Tests
2
2013
55
0.210
Why?
Swine
2
2015
408
0.210
Why?
Virus Replication
1
2024
138
0.210
Why?
Streptococcus pyogenes
1
2022
18
0.210
Why?
Antiviral Agents
1
2024
168
0.210
Why?
Fibroblasts
1
2024
354
0.200
Why?
Middle Aged
5
2019
12460
0.200
Why?
Cells, Cultured
3
2024
1589
0.180
Why?
Autoantibodies
1
2021
114
0.180
Why?
Students
1
2023
222
0.180
Why?
Infant
3
2024
3601
0.180
Why?
Enterovirus
1
2020
4
0.170
Why?
Muscle, Smooth
1
2020
64
0.170
Why?
Respiratory System
1
2020
27
0.170
Why?
Calcium Signaling
1
2020
56
0.170
Why?
Cell Differentiation
2
2024
651
0.160
Why?
Organ Culture Techniques
1
2019
48
0.160
Why?
Disease Susceptibility
1
2019
89
0.160
Why?
Mice, Inbred Strains
1
2019
160
0.160
Why?
Nasal Polyps
1
2018
4
0.150
Why?
Seroepidemiologic Studies
3
2023
49
0.150
Why?
Treatment Outcome
5
2018
5230
0.150
Why?
Acetazolamide
1
2018
18
0.150
Why?
Antibodies, Viral
3
2023
92
0.150
Why?
Pseudotumor Cerebri
1
2018
26
0.150
Why?
Albuterol
1
2019
56
0.150
Why?
RNA, Viral
2
2020
123
0.150
Why?
Food Supply
1
2019
91
0.150
Why?
Risk Factors
2
2024
3692
0.150
Why?
Host-Pathogen Interactions
1
2019
136
0.150
Why?
Parainfluenza Virus 3, Human
1
2017
5
0.140
Why?
Respirovirus Infections
1
2017
6
0.140
Why?
Immunization
2
2017
62
0.140
Why?
Cross-Sectional Studies
3
2022
1590
0.140
Why?
Prevalence
2
2019
970
0.140
Why?
Infant, Newborn
1
2024
2780
0.140
Why?
Anticonvulsants
1
2018
125
0.140
Why?
Th1-Th2 Balance
1
2016
2
0.140
Why?
Health Literacy
1
2019
129
0.140
Why?
Leukotrienes
1
2016
9
0.140
Why?
Immunocompromised Host
1
2017
119
0.130
Why?
Lymphocyte Activation
1
2016
172
0.130
Why?
Genetic Predisposition to Disease
1
2019
509
0.130
Why?
High-Throughput Nucleotide Sequencing
1
2017
168
0.130
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
122
0.130
Why?
Dose-Response Relationship, Drug
1
2019
1356
0.120
Why?
Intracellular Membranes
1
1995
26
0.120
Why?
Interleukin-17
1
2015
37
0.120
Why?
Basophils
1
2014
15
0.120
Why?
Candidiasis, Chronic Mucocutaneous
1
2014
2
0.120
Why?
Myoglobin
1
1995
25
0.120
Why?
Thymoma
1
2014
13
0.120
Why?
Oxidative Stress
1
2019
763
0.120
Why?
Eosinophil Cationic Protein
1
2014
1
0.120
Why?
Nasal Lavage Fluid
1
2014
2
0.120
Why?
Candida
1
2014
60
0.110
Why?
Decision Making, Computer-Assisted
1
2014
4
0.110
Why?
Leukocyte Count
1
2014
72
0.110
Why?
Administration, Intranasal
1
2014
30
0.110
Why?
Superantigens
1
2013
1
0.110
Why?
Intercellular Adhesion Molecule-1
1
2014
61
0.110
Why?
Markov Chains
1
2014
31
0.110
Why?
Nasal Mucosa
1
2013
19
0.110
Why?
Emergency Treatment
1
2013
30
0.110
Why?
Case-Control Studies
2
2014
1148
0.110
Why?
Preoperative Period
1
2013
48
0.110
Why?
Mice, Inbred C57BL
1
2019
1785
0.110
Why?
Decision Support Techniques
1
2014
71
0.110
Why?
Virginia
1
2013
19
0.110
Why?
Paranasal Sinuses
1
2013
16
0.110
Why?
Antibodies, Anti-Idiotypic
1
2013
19
0.110
Why?
Cats
1
2013
79
0.110
Why?
Angioedema
1
2013
9
0.110
Why?
Affect
1
2013
98
0.110
Why?
Cough
1
2013
55
0.110
Why?
Dogs
1
2013
185
0.100
Why?
Postoperative Period
1
2013
170
0.100
Why?
Acute Disease
1
2014
370
0.100
Why?
Sex Distribution
1
2013
136
0.100
Why?
Age Distribution
1
2013
170
0.100
Why?
Statistics, Nonparametric
1
2013
193
0.100
Why?
Polymerase Chain Reaction
1
2014
456
0.100
Why?
Cattle
1
2013
208
0.100
Why?
Cost-Benefit Analysis
1
2014
270
0.100
Why?
Equipment Design
1
2013
290
0.100
Why?
Pyroglyphidae
1
2012
1
0.100
Why?
Oxygen
1
1995
321
0.100
Why?
Odds Ratio
1
2014
551
0.100
Why?
Myocardium
1
1995
444
0.100
Why?
Biofilms
1
2013
181
0.100
Why?
Patient Care Team
1
2013
258
0.100
Why?
Virulence
1
2012
172
0.090
Why?
Prospective Studies
2
2017
2414
0.090
Why?
Chemokine CXCL10
2
2022
19
0.090
Why?
Antibodies, Monoclonal, Humanized
1
2013
224
0.090
Why?
Logistic Models
1
2014
900
0.090
Why?
Clinical Competence
1
2013
397
0.090
Why?
Incidence
1
2013
1017
0.080
Why?
Time Factors
2
2013
2934
0.080
Why?
Tomography, X-Ray Computed
1
2014
1160
0.080
Why?
Cohort Studies
1
2013
1426
0.080
Why?
Risk Assessment
1
2013
1258
0.080
Why?
Longitudinal Studies
2
2023
709
0.080
Why?
Genome, Viral
2
2020
79
0.070
Why?
Prognosis
1
2013
1979
0.070
Why?
United States
1
2016
4913
0.060
Why?
Respiratory Function Tests
2
2020
88
0.060
Why?
Cell Movement
1
2024
246
0.050
Why?
Interleukin-15
1
2022
16
0.050
Why?
Serologic Tests
1
2022
25
0.050
Why?
Multiple Myeloma
1
2017
2949
0.050
Why?
Epidermal Growth Factor
1
2022
33
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2022
60
0.050
Why?
Universities
1
2023
170
0.050
Why?
Interleukin-8
1
2022
86
0.050
Why?
Cluster Analysis
1
2022
231
0.050
Why?
Peptidyl-Dipeptidase A
1
2021
27
0.050
Why?
Receptor, Angiotensin, Type 1
1
2021
57
0.050
Why?
Renin-Angiotensin System
1
2021
59
0.050
Why?
Interleukin-6
1
2022
266
0.050
Why?
Angiotensin II
1
2021
162
0.040
Why?
Myosin Light Chains
1
2020
5
0.040
Why?
Placebo Effect
1
2020
16
0.040
Why?
Histamine
1
2020
25
0.040
Why?
Primary Prevention
1
2020
44
0.040
Why?
Myocytes, Smooth Muscle
1
2020
85
0.040
Why?
Inflammation Mediators
1
2020
110
0.040
Why?
Muscle Contraction
1
2020
111
0.040
Why?
Tertiary Healthcare
1
2019
15
0.040
Why?
Protein Processing, Post-Translational
1
2020
154
0.040
Why?
Hypersensitivity, Immediate
1
2018
14
0.040
Why?
Phosphorylation
1
2020
527
0.040
Why?
Coculture Techniques
1
2018
143
0.040
Why?
Double-Blind Method
1
2020
682
0.040
Why?
Immune Tolerance
1
2018
84
0.040
Why?
Air Pollutants
1
2018
65
0.040
Why?
Particulate Matter
1
2017
53
0.030
Why?
Seasons
1
2017
81
0.030
Why?
Proton Pump Inhibitors
1
2017
85
0.030
Why?
Cross Infection
1
2017
94
0.030
Why?
Environmental Exposure
1
2017
199
0.030
Why?
Partial Pressure
1
1995
14
0.030
Why?
Phosphorus
1
1995
28
0.030
Why?
Receptors, Cytokine
1
2014
11
0.030
Why?
Protons
1
1995
67
0.030
Why?
Magnetic Resonance Spectroscopy
1
1995
244
0.030
Why?
Protein-Tyrosine Kinases
1
2014
95
0.030
Why?
Adenosine Triphosphate
1
1995
230
0.030
Why?
Intracellular Signaling Peptides and Proteins
1
2014
139
0.030
Why?
Quality of Life
1
2019
844
0.030
Why?
Exhalation
1
2012
20
0.030
Why?
Epitopes
1
2012
59
0.020
Why?
Risk
1
2012
316
0.020
Why?
Rats, Sprague-Dawley
1
1995
1582
0.020
Why?
Nitric Oxide
1
2012
259
0.020
Why?
Spirometry
1
2008
30
0.020
Why?
Rats
1
1995
3287
0.020
Why?
Respiratory Therapy
1
2008
34
0.020
Why?
Adrenal Cortex Hormones
1
2008
100
0.020
Why?
Administration, Oral
1
2008
432
0.020
Why?
Practice Guidelines as Topic
1
2008
460
0.020
Why?
Severity of Illness Index
1
2008
963
0.020
Why?
Retrospective Studies
1
2017
6223
0.020
Why?
Follow-Up Studies
1
2008
2219
0.010
Why?
Kennedy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description